Two Sigma Advisers’s KalVista Pharmaceuticals KALV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,822
| Closed | -$193K | – | 2485 |
|
|
2024
Q4 | $193K | Sell |
22,822
-15,500
| -40% | -$131K | ﹤0.01% | 2132 |
|
|
2024
Q3 | $444K | Sell |
38,322
-24,800
| -39% | -$287K | ﹤0.01% | 1755 |
|
|
2024
Q2 | $744K | Sell |
63,122
-83,200
| -57% | -$980K | ﹤0.01% | 1705 |
|
|
2024
Q1 | $1.74M | Sell |
146,322
-56,200
| -28% | -$667K | ﹤0.01% | 1295 |
|
|
2023
Q4 | $2.48M | Buy |
202,522
+28,200
| +16% | +$345K | 0.01% | 1168 |
|
|
2023
Q3 | $1.68M | Buy |
174,322
+41,200
| +31% | +$397K | ﹤0.01% | 1298 |
|
|
2023
Q2 | $1.2M | Buy |
133,122
+33,500
| +34% | +$302K | ﹤0.01% | 1467 |
|
|
2023
Q1 | $783K | Sell |
99,622
-12,500
| -11% | -$98.3K | ﹤0.01% | 1755 |
|
|
2022
Q4 | $758K | Sell |
112,122
-2,500
| -2% | -$16.9K | ﹤0.01% | 1702 |
|
|
2022
Q3 | $1.66M | Sell |
114,622
-9,000
| -7% | -$131K | ﹤0.01% | 1262 |
|
|
2022
Q2 | $1.22M | Buy |
123,622
+67,900
| +122% | +$668K | ﹤0.01% | 1486 |
|
|
2022
Q1 | $821K | Sell |
55,722
-59,400
| -52% | -$875K | ﹤0.01% | 1748 |
|
|
2021
Q4 | $1.52M | Sell |
115,122
-5,300
| -4% | -$70.1K | ﹤0.01% | 1321 |
|
|
2021
Q3 | $2.1M | Buy |
120,422
+101,900
| +550% | +$1.78M | 0.01% | 1223 |
|
|
2021
Q2 | $444K | Buy |
18,522
+9,000
| +95% | +$216K | ﹤0.01% | 1990 |
|
|
2021
Q1 | $245K | Buy |
+9,522
| New | +$245K | ﹤0.01% | 2293 |
|
|
2019
Q3 | – | Sell |
-10,222
| Closed | -$226K | – | 2312 |
|
|
2019
Q2 | $226K | Buy |
+10,222
| New | +$226K | ﹤0.01% | 2099 |
|